MedTrace Logo

Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test

NCT00236171 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2010-06-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of the topical therapies Protopic and Advantan as well as their combination against placebo in a Psoriasis Plaque Test

Conditions

  • Psoriasis Vulgaris

Interventions

DRUG

Protopic, Advantan

PROCEDURE

Blood and Urine Test

PROCEDURE

coherence tomography

Sponsors & Collaborators

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Gottfried Wozel, Professor · Technische Universität Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2006-04-30
Completion
2010-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00236171 on ClinicalTrials.gov